NCT01540227 - Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 10, 2016

Study Completion Date

November 10, 2016

Conditions

SyphilisPrimary SyphilisSecondary SyphilisEarly-Latent Syphilis

Interventions

DRUG

Regular Treatment for Syphilis

"Drug: Benzathine Penicillin G (Bicillin)~Dose: 2.4 million units~Mode of Administration: intramuscular injection~Duration of Treatment: one dose~Health Canada approved indication: Yes"

Trial Locations (3)

K1H 8L6

The Ottawa Hospital, Ottawa

K1N 5P7

Ottawa Sexual Health Clinic/GayZone, Ottawa

M5G 2C4

Toronto General Hospital, Toronto